ºÝºÝߣ

ºÝºÝߣShare a Scribd company logo
MarcusEvansPharma

Life Sciences Network marcus evans

42 ºÝºÝߣShares14 Followers
42 ºÝºÝߣShares14 Followers
Personal Information
Industry
Medical / Health Care / Pharmaceuticals
Website
About
For more information contact: moreinfo@marcusevanscy.com. The marcus evans Pharma Division delivers high level business events for the pharmaceuticals community. Our Summits are designed to meet the networking, knowledge and business requirements of executives working for the pharmaceuticals, biotechnology, drug discovery and development fields.

Presentations(29)Ìý

See all
From In Silco to In Vivo – Modeling and Simulation Technologies, a Tool for Optimized Drug Development - Joseph Fleishaker, Pfizer Inc.
From In Silco to In Vivo – Modeling and Simulation Technologies, a Tool for Optimized Drug Development - Joseph Fleishaker, Pfizer Inc.From In Silco to In Vivo – Modeling and Simulation Technologies, a Tool for Optimized Drug Development - Joseph Fleishaker, Pfizer Inc.
From In Silco to In Vivo – Modeling and Simulation Technologies, a Tool for Optimized Drug Development - Joseph Fleishaker, Pfizer Inc.
Ìý
Carving a New Niche for Non-Profits: Filling the Translational Gap for Novel Treatments for Diseases with Unmet Needs - Scott Johnson, Myelin Repair Foundation
Carving a New Niche for Non-Profits: Filling the Translational Gap for Novel Treatments for Diseases with Unmet Needs - Scott Johnson, Myelin Repair FoundationCarving a New Niche for Non-Profits: Filling the Translational Gap for Novel Treatments for Diseases with Unmet Needs - Scott Johnson, Myelin Repair Foundation
Carving a New Niche for Non-Profits: Filling the Translational Gap for Novel Treatments for Diseases with Unmet Needs - Scott Johnson, Myelin Repair Foundation
Ìý
The Importance of Developing a Global Regulatory Strategy towards the Goal of Registration - Carlos Langezaal, Eisai Inc
The Importance of Developing a Global Regulatory Strategy towards the Goal of Registration - Carlos Langezaal, Eisai IncThe Importance of Developing a Global Regulatory Strategy towards the Goal of Registration - Carlos Langezaal, Eisai Inc
The Importance of Developing a Global Regulatory Strategy towards the Goal of Registration - Carlos Langezaal, Eisai Inc
Ìý

Documents(13)Ìý

See all
Best Indicators of Clinical Development Success - Tom Macek, Takeda Global Research and Development
Best Indicators of Clinical Development Success - Tom Macek, Takeda Global Research and DevelopmentBest Indicators of Clinical Development Success - Tom Macek, Takeda Global Research and Development
Best Indicators of Clinical Development Success - Tom Macek, Takeda Global Research and Development
Ìý
Moving with the Times for Better Drug Development: Interview with: Hasse Kromann, Head of Section R&D Partnership Management, Innovation & Research, LEO Pharma
Moving with the Times for Better Drug Development: Interview with: Hasse Kromann, Head of Section R&D Partnership Management, Innovation & Research, LEO PharmaMoving with the Times for Better Drug Development: Interview with: Hasse Kromann, Head of Section R&D Partnership Management, Innovation & Research, LEO Pharma
Moving with the Times for Better Drug Development: Interview with: Hasse Kromann, Head of Section R&D Partnership Management, Innovation & Research, LEO Pharma
Ìý
How to Speed Up the FDA Drug Approval System: Interview with: Bruce Thompson, President, Clinical Trials & Surveys Corp
How to Speed Up the FDA Drug Approval System: Interview with: Bruce Thompson, President, Clinical Trials & Surveys CorpHow to Speed Up the FDA Drug Approval System: Interview with: Bruce Thompson, President, Clinical Trials & Surveys Corp
How to Speed Up the FDA Drug Approval System: Interview with: Bruce Thompson, President, Clinical Trials & Surveys Corp
Ìý